{
    "eid": "2-s2.0-85165253221",
    "title": "The allopurinol metabolite, oxypurinol, drives oligoclonal expansions of drug-reactive T cells in resolved hypersensitivity cases and drug-na\u00efve healthy donors",
    "cover-date": "2023-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology and Allergy",
            "@code": "2723",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        }
    ],
    "keywords": [
        "allopurinol",
        "drug hypersensitivity reaction",
        "oxypurinol",
        "T-cell receptor"
    ],
    "authors": [
        "Nicole A. Mifsud",
        "Patricia T. Illing",
        "Rebecca Ho",
        "Johanna E. Tuomisto",
        "Heidi Fettke",
        "Kerry A. Mullan",
        "James McCluskey",
        "Jamie Rossjohn",
        "Julian Vivian",
        "Rangsima Reantragoon",
        "Anthony W. Purcell"
    ],
    "citedby-count": 0,
    "ref-count": 51,
    "ref-list": [
        "Allopurinol hypersensitivity: investigating the cause and minimizing the risk",
        "Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinol",
        "Demonstration of a combined deficiency of xanthine oxidase and aldehyde oxidase in xanthinuric patients not forming oxipurinol",
        "Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel",
        "Insights into the poor prognosis of allopurinol-induced severe cutaneous adverse reactions: the impact of renal insufficiency, high plasma levels of oxypurinol and granulysin",
        "Excess of ampicillin rashes associated with allopurinol or hyperuricemia. A Report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center",
        "Acute adverse reactions attributed to allopurinol in hospitalised patients",
        "DRESS syndrome: part II. Management and therapeutics",
        "Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis",
        "Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012",
        "HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol",
        "A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs",
        "HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis",
        "Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population",
        "HLA-B*58:01 is a risk factor for allopurinol-induced DRESS and Stevens-Johnson syndrome/toxic epidermal necrolysis in a Portuguese population",
        "Positive and negative associations of HLA class I alleles with allopurinol-induced SCARs in Koreans",
        "Impact of the HLA-B(*)58:01 allele and renal impairment on allopurinol-induced cutaneous adverse reactions",
        "HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human alpha beta T lymphocytes",
        "Allotype specific interactions of drugs and HLA molecules in hypersensitivity reactions",
        "Pharmacogenetics of drug hypersensitivity",
        "Allopurinol hypersensitivity is primarily mediated by dose-dependent oxypurinol-specific T cell response",
        "Immunologic basis for allopurinol-induced severe cutaneous adverse reactions: HLA-B*58:01-restricted activation of drug-specific T cells and molecular interaction",
        "Oxypurinol-specific T cells possess preferential TCR Clonotypes and express Granulysin in allopurinol-induced severe cutaneous adverse reactions",
        "Oxypurinol directly and immediately activates the drug-specific T cells via the preferential use of HLA-B*58:01",
        "Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome",
        "Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones",
        "Carbamazepine induces focused T cell responses in resolved Stevens-Johnson syndrome and toxic epidermal necrolysis cases but does not perturb the Immunopeptidome for T cell recognition",
        "Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions",
        "Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis",
        "Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells",
        "The HLA-A,B \"negative\" mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon",
        "Production of monoclonal antibodies to group a erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis",
        "Rapid screening for the detection of HLA-B57 and HLA-B58 in prevention of drug hypersensitivity",
        "Quantitative and functional diversity of cross-reactive EBV-specific CD8+ T cells in a longitudinal study cohort of lung transplant recipients",
        "T cell receptor alphabeta diversity inversely correlates with pathogen-specific antibody levels in human cytomegalovirus infection",
        "IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis",
        "Protein displays of the human T cell receptor alpha, beta, gamma and delta variable and joining regions",
        "TCR_Explore: a novel webtool for T cell receptor repertoire analysis",
        "Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector",
        "Recognition of distinct cross-reactive virus-specific CD8+ T cells reveals a unique TCR signature in a clinical setting",
        "Identification of drug-specific public TCR driving severe cutaneous adverse reactions",
        "Some adverse reactions to allopurinol may be mediated by lymphocyte reactivity to oxypurinol",
        "Cell-mediated immunity in allopurinol-induced hypersensitivity",
        "The p-i concept: pharmacological interaction of drugs with immune receptors",
        "Immune self-reactivity triggered by drug-modified HLA-peptide repertoire",
        "Abacavir induces loading of novel self-peptides into HLA-B*57: 01: an autoimmune model for HLA-associated drug hypersensitivity",
        "Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire",
        "Immunodominance hierarchies and gender bias in direct T(CD8)-cell alloreactivity",
        "T-cells from HLA-B*57:01+ human subjects are activated with abacavir through two independent pathways and induce cell death by multiple mechanisms",
        "Single-cell transcriptomics reveal polyclonal memory T-cell responses in skin with positive abacavir patch test results",
        "Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome"
    ],
    "affiliation": [
        {
            "affiliation-city": "Melbourne",
            "@id": "60117340",
            "affilname": "The Peter Doherty Institute for Infection and Immunity",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60117340",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Cardiff",
            "@id": "60103683",
            "affilname": "Cardiff University School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60103683",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Clayton",
            "@id": "60012932",
            "affilname": "Faculty of Medicine, Nursing and Health Sciences",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012932",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "NeCTAR",
        "National Health and Medical Research Council of Australia",
        "Monash University Faculty of Medicine, Nursing and Health Sciences"
    ]
}